Effects of Fingolimod and Natalizumab on Slowly Expanding Lesion Occurrence over Two Years of Treatment in Relapsing-remitting Multiple Sclerosis (1317) — Paolo Preziosa (2020) | RDL Network
Effects of Fingolimod and Natalizumab on Slowly Expanding Lesion Occurrence over Two Years of Treatment in Relapsing-remitting Multiple Sclerosis (1317)
Article 2020 en
Authors
PP
Paolo Preziosa
EP
Elisabetta Pagani
LM
Lucia Moiola
Abstract
1 min read
To compare the effects of fingolimod and natalizumab on the occurrence of white matter lesions showing a progressive linear enlargement over two years of treatment, a putative biomarker of smouldering inflammation.
Paolo Preziosa, Maria A. Rocca, Gianna Carla Riccitelli, Mariaemma Rodegher, Massimiliano Copetti, Lucia Moiola, Francesco Mele, Andrea Falini, Giancarlo Comi, Massimo Filippi
Discussion(0)
No comments yet. Be the first to comment.